Free Newsletter
McCain among patients switched off Vytorin
SPOTLIGHT: McCain among patients switched off Vytorin
Count Sen. John McCain's prescription for Vytorin among the Enhance study casualties. After the study was presented at the American College of Cardiology meeting--and the New England Journal of Medicine recommended that Vytorin only be used as a cholesterol fighter after trying several other alternatives--McCain's cardiologist switched him to simvastatin, a Zocor generic. (Zocor, remember, is one component of the Vytorin combo drug, which also includes Zetia.) His "bad" cholesterol went up then, to 123 from 83, but his docs appear to be satisfied with that. Other cardiologists say the presidential candidate should be on a higher dose of simvastatin or try another, more potent statin. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: